How to Get Mounjaro Cheaper: Making Sense of UK Private Pricing

What the UK market price actually reflects right now

Mounjaro's private pricing landscape changed sharply in late 2025. Eli Lilly adjusted its UK list price for the highest-dose pen from roughly £122 to around £330 per four-week supply from 1 September 2025, and that shift worked its way through to most private providers relatively quickly. If you saw prices on a comparison site months ago, they are probably out of date. Our own coverage of the Mounjaro price change sets out what happened and why, if you want the background.

The current private range (reported broadly as £149 to £375 per month) reflects the full titration ladder from the 2.5mg starter pen up to 15mg. Lower doses cost less. That is relevant because treatment does not begin at the highest strength; it starts low and increases as your body adjusts, usually in four-week steps guided by your prescriber. So comparing a lowest-dose quote against a highest-dose quote gives you a misleading picture of what you would actually spend in any given month.

NICE's recommendation for tirzepatide (TA1026) sets out the clinical criteria for NHS access, but NHS availability remains highly restricted and phased, for most people right now, private prescription is the only realistic route. You can read the current Mounjaro pricing detail on our treatment page, which is updated as things change.

What headline prices often leave out, and why the gap matters

A low advertised number sometimes does not include a consultation fee, a prescription charge, delivery, or any form of ongoing clinical support. Add those separately and the gap closes fast. This is worth being deliberate about, especially if you are comparing services ahead of payday or planning around a bank-holiday week when next-day delivery windows shift.

The things most likely to be excluded from a headline price include: the initial consultation (sometimes charged separately at £20–£50), a repeat prescription review fee, delivery (which can be £5–£15 per order), and any aftercare or messaging support between orders. If you need a dose increase, some providers charge an additional clinical review fee for that too. None of these are hidden in any dishonest sense, they are just not always upfront in the number being advertised.

Our guide to the cheapest way to get Mounjaro walks through what genuine all-in costs look like across a full treatment course, so you can do the comparison properly rather than headline-to-headline. The NHS tirzepatide page at nhs.uk/medicines/tirzepatide is also worth reading for a neutral overview of what the medicine is and what to expect from it.

The decision: what 'cheaper' actually means for a prescription medicine

Here is the honest position. At nume, we are not the cheapest option on the market, and that is a deliberate choice, not an oversight. One price covers your consultation, your prescription, the medicine, and next-working-day DPD delivery. Priority clinical support runs seven days a week. Every repeat order goes back in front of a prescriber for review. We built the service around safety infrastructure (photo ID verification, live weight confirmation, GP notification in line with GPhC guidance) because cutting those steps is how services cut prices.

The question of how you can get Mounjaro cheaper is really a question about what you are willing to trade off. A lower price that omits clinical re-review means no one checks whether your dose is still appropriate, whether you have developed a new health condition, or whether you are using the pen correctly. A closer look at what cheap Mounjaro offers typically include is worth a few minutes of your time before you decide.

If you have seen social media sellers offering Mounjaro well below market rates, the MHRA has been explicit: counterfeit GLP-1 pens are circulating in the UK, some have caused hospitalisations, and around 20 million doses of illegally traded weight-loss medicines (worth approximately £45 million) were seized in 2025 alone. Sellers operating without a full UK prescription process are a red flag, not a bargain. You can verify any UK online pharmacy using the GPhC pharmacy register, if it is not listed, do not buy from it.

What to do if cost is a genuine barrier

If private pricing is simply out of reach, NHS access is the other route, though the eligibility criteria are tight and the waiting lists in most areas are long. NICE's phased rollout (TA1026) is opening access gradually, with a new cohort qualifying from around June 2026 and further expansion expected into 2027, and if you are wondering whether Mounjaro is going to get cheaper as that rollout progresses, we cover what the current evidence suggests. You can read more about how NHS access is currently structured on our Mounjaro overview page, which covers both private and NHS routes in plain terms.

It is also worth knowing that treatment typically costs less at lower doses, and most people spend several months on starter and mid-range doses before reaching maintenance strength. A full-price month at 2.5mg costs considerably less than a full-price month at 15mg. Our weight-loss treatment overview explains how the titration process works and what to expect through the different stages, which helps with planning.

If you have questions about whether your situation fits the eligibility criteria, or you want to understand the consultation process before committing, the frequently asked questions page covers most of what people ask us before they start. And if you want to talk to us directly, the contact page is always open. When you are ready, checking your eligibility through a free consultation is the first practical step, it costs nothing, and a real prescriber reviews your answers the same day.

Check your eligibility with a free consultation.